Breathlessness is one of the most common symptoms experienced at the end of life, affecting all areas of a patient’s life. It is frightening and leads to high rates of emergency hospital attendances. Often, there is no easily reversible cause and patients are admitted to the acute medical unit (AMU) in order to manage their symptoms with little overall benefit – frustrating patients and clinicians alike. This review reminds the generalist of the significance of breathlessness as a symptom. It highlights the management strategies available to effect improvement and gives practical tips on how this can be achieved within the busy and time-pressured environment of the AMU.

[download-attachments container="div" style="list" display_icon="1" display_count="1" display__size="0"]

References

1. Parshall M, Schwartzstein R, Adams L, et al. An Official American Thoracic Society Statement: Update on the Mechanism, Assessment, and Management of Dyspnea. Am. J. Respir. Crit. Med. 2012; 185(4): 435-452.
2. Mulrow C, Lucey C and Farnett L. Discriminating causes of dyspnea through clinical examination. J. Gen. Intern. Med. 1993; 8: 383-392.
3. Cleary J and Carbone P. Palliative medicine in the elderly. Cancer 1997; 80(7): 1335-1337.
4. Solano J, Gomes B and Higginson I. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J. Pain Symptom Manage. 2006; 31: 58-59.
5. National End of Life Care Intelligence Network (2010). Hospital admissions in the last year of life and death in hospital. Retrieved from www.endoflifecare-intelligence.org.uk/view?rid=480.
6. Escalante C, Martin C, Elting L, et al. Dyspnea in cancer patients. Cancer 1996; 78: 1314-1319.
7. Booth S, Silvester S and Todd C. Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers. Palliat. Support Care 2003; 1(4): 337-344.
8. Fallon M and Hanks G. ABC of Palliative Care. John Wiley & Sons, Incorporated 2006.
9. Abernathy A and Wheeler J. Total dyspnea. Curt. Opin. Support. Palliat. Care 2008; 2: 110-113.
10. Kamal A, Maguire J, Wheeler J, et al. Dyspnea Review for the Palliative Care Professional: Assessment, Burdens, and Etiologies. J. Palliat. Med. 2011; 14(10): 1167-1172.
11. Chaves et al. Symptoms of dysphagia in patients with COPD. J. Bras. Pneumol. 2011; 37(2): 176-183.
12. Moody L, McCormick K and Williams A. Disease and symptom severity, function status, and quality of life in chronic bronchitis and emphysema. J Behav. Med. 1990; 13: 297-304.
13. Citizens Advice Bureaux (2017). Duty to make reasonable adjustments at work - what must employers do? Retrieved from https://www.citizensadvice.org.uk/work/discrimination-at-work/ what-are-the-different-types-of-discrimination/duty-to-makereasonable-adjustments-at-work-what-must-employers-do/
14. Redek T, Susjan A and Kostevc C. Unemployment and SelfConcept. Economic Research 2013; 26(1): 185-200.
15. Schulz R and Eden J. Families Caring for an Aging America. The National Academy of Sciences, Engineering and Medicine. The National Academies Press, Washington, DC 2016.
16. British Lung Foundation (2017). Sex and breathlessness. Retrieved from https://www.blf.org.uk/support-for-you/sex-andbreathlessness/suggestions
17. Ganz B. Psychosocial issues in lung cancer patients (Part 2). Chest 1991; 99: 480-485.
18. Barbera L, Taylor C and Dudgeon D. Why do patients with cancer visit the emergency department near the end of life? CMAJ 2010; 182(6): 563-568.
19. Moody L and McMullan S. Dyspnea and quality of life indicators in hospice patients and their caregivers. Health Qual. Life Outcomes 2003; 1: 9.
20. Reddy S, Parsons H and Elsayem A. Characteristics and correlates of dyspnea with advance cancer. J Palliat. Med. 2009; 12(1): 29-36.
21. Szczepura A. Access to health care for ethnic minority populations. Postgrad. Med. J. 2005; 81: 141-147.
22. Pinnock H et al. Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study. BMJ 2011; 342: d142.
23. Dorman S, Byrne A and Edwards A. Which measurement scales should we use to measure breathlessness in palliative care? A systematic review. Palliat. Med. 2007; 21(3): 177-191.
24. Ries A, Bauldoff G, Carlin B, et al. Pulmonary rehabilitation: Joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest 2007; 131: 4S-42S.
25. British Thoracic Society (2009). Concise BTS/ACPRC guidelines. Physiotherapy management of the adult, medical, spontaneously breathing patient. Retrieved from https://www.brit-thoracic. org.uk/document-library/clinical-information/physiotherapy/ physiotherapy-guidelines/physiotherapy-concise-guideline/
26. Bott J, Blumenthal S, Buxton M, et al. Joint BTS/ACPRC Guideline: Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax 2009; 64: i1-i52
27. Boulding R, Stacy R, Niven R and Fowler S. Dysfunctional breathing: a review of the literature and proposal for classification. Eur. Respir. Rev . 2016; 25: 287-294.
28. Spathis A et al. The Breathing, Thinking, Functioning clinical model: a proposal to facilitate evidence-based breathlessness management in chronic respiratory disease. NPJ Prim. Care Respir. Med. 2017; 27: 27.
29. Giffford A. Noninvasive ventilation as a palliative measure. Curr. Opin. Support. Palliat. Care 2014; 8: 218–224.
30. Sinuff et al. Noninvasive ventilation for acute respiratory failure near the end of life. Crit. Care Med. 2008; 36: 789–794.
31. NICE (2016) Palliative care - dyspnoea (Clinical Knowledge Summary). Retrieved from https://cks.nice.org.uk/palliative-caredyspnoea.
32. Schwartzstein R, Lahive K et al. Cold facial stimulation reduces breathlessness induced in normal subjects. Am. Rev. Respir. Dis. 1987; 136: 58-61.
33. Galbraith S, Fagan P, Perkins P, et al. Does the use of a handheld fan improve chronic dyspnea? A randomised, controlled, crossover trial. J. Pain Symptom Manage. 2010; 39: 831-838.
34. Abernethy A, McDonald C, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet 2010; 376: 784-793.
35. Smoller J, Pollack M, Otto M, et al. Panic anxiety, dyspnea and respiratory disease. Theoretical and clinical considerations. Am. J. Respir. Crit. Med. 1996; 154(1): 6-17.
36. Farver-Vestergaard I, Jacobsen D and Zachariaae T. Efficacy of psychosocial interventions on psychological and physical health outcomes in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Psychother. Psychosom. 2015; 84: 37-50.
37. Norweg A and Collins E. Evidence of cognitive-behavioural strategies improving dyspnea and related distress in COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 2013; 8: 439-451.
38. Abell F, Potter C, Purcell S, et al. The effect of inclusion of a clinical psychologist in pulmonary rehabilitation on completion rates and hospital resource utilisation (hospital admissions and bed days) in chronic obstructive pulmonary disease. Abstract presented at 2008 Winter Meeting of the British Thoracic Society. [online] www. brit-thoracic.org.uk/Portals/0/Education%20Hub/Winter%20 Meeting/WMProg08.pdf.
39. Mularski R, Munja B, Lorenz K, et al. Randomized controlled trial of mindfulness-based therapy for dyspnea in chronic obstructive lung disease. J. Altern. Complement. Med. 2009; 15: 1083-1090.
40. Bausewein C, Booth S, Gysels M, Higginson I. Nonpharmacological interventions for breathlessness in advance stages of malignant and non-malignant diseases. Cochrane Database Syst. Rev. 2008 (2): CD005623.
41. Barnes et al. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database Syst. Rev. 2016; 3: CD011008.
42. Ekstrom et al. One evidence base; three stories: do opioids relieve chronic breathlessness? Thorax 2018; 73(1): 88-90.
43. Davis et al. Looking both ways before crossing the street: Assessing the benefits and risk of opioids in treating patients at risk of sleep -disordered breathing for pain and dyspnea. J. Opioid Manag. 2017; 13(3): 183-196.
44. Verberkt C et al. Respiratory adverse effects of opioids for breathlessness: a systematic review and meta-analysis. Eur. Respir. J. 2017; 50: 1701153.
45. Jennings A, Davies A, Higgings J, et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002; 57: 939-944.
46. George R et al. Lethal opioid or dangerous prescribers? Palliat. Med. 2007; 21: 1-4.
47. Navigante A, Cerchietti L, Castro M, et al. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J. Pain Symptom Manage. 2006; 31: 38-47.
48. Roberts C. Short burst oxygen therapy for relief of breathlessness in COPD. Thorax 2004; 59: 638-640.
49. British Thoracic Society. BTS Guidelines for Home Oxygen Use in Adults. Thorax 2015; 70(1): i1-i43.
50. Chu D et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. Lancet 2018; 391(10131): 1693-1705.
51. Sabo B and Johnston G. Understanding the challenges to improve transition to palliative care: An issue for the primary malignant brain tumour population. Can. J. Neurosci. Nurs. 2016; 38(1): 48-55.
52. Revitt O, Sewell L, Morgan M, Steiner M, Singh S. Short outpatient pulmonary rehabilitation programme reduces readmission following a hospitalization for an exacerbation of chronic obstructive pulmonary disease. Respirology 2013; 18(7): 1063-1068